{"openapi_url": "https://raw.githubusercontent.com/CanDIG/katsu/develop/chord_metadata_service/mohpackets/docs/schema.yml", "schema_class": "MoHSchema", "donors": [{"cause_of_death": "Died of other reasons", "date_resolution": "day", "date_of_death": {"month_interval": 37, "day_interval": 1110}, "gender": "Man", "is_deceased": true, "program_id": "SYNTHETIC-1", "sex_at_birth": "Female", "submitter_donor_id": "DONOR_1", "primary_diagnoses": [{"basis_of_diagnosis": "Cytology", "cancer_type_code": "C02.1", "clinical_m_category": "M1a(1)", "clinical_stage_group": "Stage IIIAE", "clinical_t_category": "T4d", "clinical_tumour_staging_system": "Ann Arbor staging system", "date_of_diagnosis": {"month_interval": 3, "day_interval": 90}, "laterality": "Midline", "lymph_nodes_examined_method": "Imaging", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 9, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1", "specimens": [{"pathological_m_category": "MX", "pathological_stage_group": "Stage IEB", "pathological_t_category": "T1", "pathological_tumour_staging_system": "Binet staging system", "percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "Yes", "reference_pathology_confirmed_tumour_presence": "Unknown", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 46, "day_interval": 1380}, "specimen_laterality": "Not applicable", "specimen_processing": "Other", "specimen_storage": "Unknown", "submitter_specimen_id": "SPECIMEN_1", "tumour_grade": "Grade Group 5", "tumour_grading_system": "Three-tier grading system", "tumour_histological_type": "8962/1", "sample_registrations": [{"sample_type": "Other DNA enrichments", "specimen_tissue_source": "Abdominal fluid", "specimen_type": "Cell line - derived from metastatic tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_1", "tumour_normal_designation": "Tumour"}, {"sample_type": "Other RNA fractions", "specimen_tissue_source": "Arterial blood", "specimen_type": "Cell line - derived from normal", "submitter_sample_id": "SAMPLE_REGISTRATION_2", "tumour_normal_designation": "Tumour"}, {"sample_type": "Total RNA", "specimen_tissue_source": "Cerebrospinal fluid", "specimen_type": "Primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_3", "tumour_normal_designation": "Tumour"}]}, {"pathological_m_category": "MX", "pathological_n_category": "N0b (no biopsy)", "pathological_stage_group": "Stage IE", "pathological_t_category": "T1b(m)", "pathological_tumour_staging_system": "AJCC 6th edition", "percent_tumour_cells_measurement_method": "Unknown", "percent_tumour_cells_range": "20-50%", "reference_pathology_confirmed_diagnosis": "Unknown", "reference_pathology_confirmed_tumour_presence": "Yes", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 23, "day_interval": 690}, "specimen_laterality": "Not applicable", "specimen_processing": "Cryopreservation - other", "submitter_specimen_id": "SPECIMEN_2", "tumour_grade": "Grade Group 2", "tumour_grading_system": "IASLC grading system", "tumour_histological_type": "8250/3", "sample_registrations": [{"sample_type": "rRNA-depleted RNA", "specimen_tissue_source": "Solid tissue", "specimen_type": "Xenograft - derived from metastatic tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_4", "tumour_normal_designation": "Normal"}, {"specimen_tissue_source": "Buccal cell", "specimen_type": "Xenograft - derived from tumour cell line", "submitter_sample_id": "SAMPLE_REGISTRATION_5", "tumour_normal_designation": "Tumour"}, {"specimen_tissue_source": "Convalescent plasma", "specimen_type": "Cell line - derived from xenograft tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_6", "tumour_normal_designation": "Normal"}]}, {"pathological_m_category": "M1d(0)", "pathological_n_category": "N0a", "pathological_stage_group": "Stage 2B", "pathological_t_category": "Ta", "pathological_tumour_staging_system": "FIGO staging system", "percent_tumour_cells_measurement_method": "Genomics", "reference_pathology_confirmed_diagnosis": "Not done", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 34, "day_interval": 1020}, "specimen_laterality": "Left", "specimen_storage": "Other", "submitter_specimen_id": "SPECIMEN_3", "tumour_grade": "Grade 1", "tumour_grading_system": "FNCLCC grading system", "tumour_histological_type": "8479/2", "sample_registrations": [{"sample_type": "Other DNA enrichments", "specimen_tissue_source": "Cord blood", "specimen_type": "Recurrent tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_7", "tumour_normal_designation": "Tumour"}, {"sample_type": "ctDNA", "specimen_tissue_source": "Amniotic fluid", "submitter_sample_id": "SAMPLE_REGISTRATION_8", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 4, "is_primary_treatment": "Unknown", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment": "Immune uncomfirmed progressive disease (iUPD)", "response_to_treatment_criteria_method": "RECIST 1.1", "status_of_treatment": "Treatment completed as prescribed", "submitter_treatment_id": "TREATMENT_1", "treatment_end_date": {"month_interval": 96, "day_interval": 2880}, "treatment_intent": "Diagnostic", "treatment_setting": "Salvage", "treatment_start_date": {"month_interval": 21, "day_interval": 630}, "treatment_type": ["Chemotherapy"], "chemotherapies": [{"actual_cumulative_drug_dose": 60, "chemotherapy_drug_dose_units": "IU/kg", "drug_name": "Ado-Trastuzumab", "drug_reference_database": "RxNorm", "drug_reference_identifier": "836494", "prescribed_cumulative_drug_dose": 320}, {"actual_cumulative_drug_dose": 100, "chemotherapy_drug_dose_units": "ug/m2", "drug_name": "Thalidomide", "drug_reference_identifier": "56438", "prescribed_cumulative_drug_dose": 4600}, {"chemotherapy_drug_dose_units": "ug/m2", "drug_name": "Gemcitabine", "drug_reference_database": "NCI Thesaurus", "prescribed_cumulative_drug_dose": 320}], "followups": [{"date_of_followup": {"month_interval": 27, "day_interval": 810}, "date_of_relapse": {"month_interval": 41, "day_interval": 1230}, "disease_status_at_followup": "Loco-regional progression", "method_of_progression_status": ["Laboratory data interpretation (procedure)", "Tumor marker measurement (procedure)"], "recurrence_m_category": "M1a(0)", "recurrence_stage_group": "Stage IVES", "recurrence_t_category": "T4b(s)", "relapse_type": "Local recurrence", "submitter_follow_up_id": "FOLLOW_UP_1"}, {"date_of_relapse": {"month_interval": 44, "day_interval": 1320}, "disease_status_at_followup": "Distant progression", "method_of_progression_status": ["Physical examination procedure (procedure)", "Laboratory data interpretation (procedure)"], "recurrence_m_category": "M0", "recurrence_n_category": "N0(mol-)", "recurrence_stage_group": "Stage 1", "recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System", "submitter_follow_up_id": "FOLLOW_UP_2"}]}, {"days_per_cycle": 6, "is_primary_treatment": "Yes", "number_of_cycles": 3, "response_to_treatment": "Stable disease", "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)", "status_of_treatment": "Patient choice (stopped or interrupted treatment)", "submitter_treatment_id": "TREATMENT_2", "treatment_intent": "Diagnostic", "treatment_setting": "Radiosensitization", "treatment_type": ["Bone marrow transplant", "Hormonal therapy"], "chemotherapies": [{"actual_cumulative_drug_dose": 60, "chemotherapy_drug_dose_units": "mg/m2", "drug_name": "Rucaparib", "drug_reference_database": "RxNorm", "drug_reference_identifier": "876459", "prescribed_cumulative_drug_dose": 780}, {"actual_cumulative_drug_dose": 90, "chemotherapy_drug_dose_units": "IU/kg", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "6534648", "prescribed_cumulative_drug_dose": 150}, {"actual_cumulative_drug_dose": 90, "chemotherapy_drug_dose_units": "IU/m2", "drug_name": "Goserelin", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "87354", "prescribed_cumulative_drug_dose": 780}], "followups": [{"date_of_followup": {"month_interval": 9, "day_interval": 270}, "date_of_relapse": {"month_interval": 39, "day_interval": 1170}, "disease_status_at_followup": "Distant progression", "method_of_progression_status": ["Assessment of symptom control (procedure)", "Physical examination procedure (procedure)"], "recurrence_n_category": "N1c", "recurrence_t_category": "Tis(Paget's)", "recurrence_tumour_staging_system": "International Neuroblastoma Staging System", "relapse_type": "Biochemical progression", "submitter_follow_up_id": "FOLLOW_UP_5"}]}, {"days_per_cycle": 3, "is_primary_treatment": "Unknown", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment": "Morphologic leukemia-free state", "response_to_treatment_criteria_method": "Physician Assessed Response Criteria", "status_of_treatment": "Treatment stopped due to acute toxicity", "submitter_treatment_id": "TREATMENT_3", "treatment_end_date": {"month_interval": 70, "day_interval": 2100}, "treatment_intent": "Supportive", "treatment_setting": "Locally advanced", "treatment_start_date": {"month_interval": 49, "day_interval": 1470}, "treatment_type": ["Other targeting molecular therapy", "Photodynamic therapy"], "chemotherapies": [{"actual_cumulative_drug_dose": 66, "chemotherapy_drug_dose_units": "IU/kg", "drug_name": "Trametinib", "drug_reference_database": "NCI Thesaurus", "prescribed_cumulative_drug_dose": 320}, {"actual_cumulative_drug_dose": 111, "drug_name": "Erlotinib", "drug_reference_database": "PubChem", "drug_reference_identifier": "836754", "prescribed_cumulative_drug_dose": 780}, {"actual_cumulative_drug_dose": 66, "chemotherapy_drug_dose_units": "IU/m2", "drug_name": "Ponatinib", "drug_reference_database": "PubChem", "drug_reference_identifier": "7365837"}], "followups": [{"date_of_followup": {"month_interval": 7, "day_interval": 210}, "date_of_relapse": {"month_interval": 35, "day_interval": 1050}, "disease_status_at_followup": "Complete remission", "method_of_progression_status": ["Assessment of symptom control (procedure)", "Laboratory data interpretation (procedure)"], "recurrence_n_category": "N0b", "recurrence_t_category": "T3e", "recurrence_tumour_staging_system": "International Neuroblastoma Risk Group Staging System", "relapse_type": "Biochemical progression", "submitter_follow_up_id": "FOLLOW_UP_9"}, {"anatomic_site_progression_or_recurrence": ["C05"], "date_of_followup": {"month_interval": 13, "day_interval": 390}, "date_of_relapse": {"month_interval": 20, "day_interval": 600}, "disease_status_at_followup": "Relapse or recurrence", "method_of_progression_status": ["Laboratory data interpretation (procedure)", "Physical examination procedure (procedure)"], "recurrence_m_category": "M1", "recurrence_n_category": "N2c", "recurrence_stage_group": "Stage IIIC2", "recurrence_t_category": "T4a(m)", "recurrence_tumour_staging_system": "AJCC 8th edition", "relapse_type": "Local recurrence and distant metastasis", "submitter_follow_up_id": "FOLLOW_UP_7"}, {"anatomic_site_progression_or_recurrence": ["C01", "C14"], "date_of_followup": {"month_interval": 33, "day_interval": 990}, "date_of_relapse": {"month_interval": 31, "day_interval": 930}, "disease_status_at_followup": "Complete remission", "recurrence_m_category": "MX", "recurrence_n_category": "N3b", "recurrence_stage_group": "Stage IIAES", "recurrence_t_category": "T4", "recurrence_tumour_staging_system": "AJCC 6th edition", "relapse_type": "Local recurrence", "submitter_follow_up_id": "FOLLOW_UP_8"}]}], "followups": [{"date_of_followup": {"month_interval": 3, "day_interval": 90}, "date_of_relapse": {"month_interval": 10, "day_interval": 300}, "disease_status_at_followup": "Partial remission", "recurrence_m_category": "M1d(0)", "recurrence_n_category": "N0b (no biopsy)", "recurrence_stage_group": "Stage II bulky", "recurrence_t_category": "T3", "recurrence_tumour_staging_system": "FIGO staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_6"}, {"anatomic_site_progression_or_recurrence": ["C15"], "date_of_followup": {"month_interval": 15, "day_interval": 450}, "date_of_relapse": {"month_interval": 26, "day_interval": 780}, "disease_status_at_followup": "No evidence of disease", "method_of_progression_status": ["Imaging (procedure)"], "recurrence_m_category": "M1c(0)", "recurrence_n_category": "N1b", "recurrence_stage_group": "Stage IVB", "recurrence_t_category": "Tis(Paget)", "recurrence_tumour_staging_system": "Durie-Salmon staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_4"}, {"anatomic_site_progression_or_recurrence": ["C11", "C19"], "date_of_followup": {"month_interval": 36, "day_interval": 1080}, "date_of_relapse": {"month_interval": 47, "day_interval": 1410}, "disease_status_at_followup": "Stable", "method_of_progression_status": ["Histopathology test (procedure)", "Tumor marker measurement (procedure)"], "recurrence_n_category": "NX", "recurrence_stage_group": "Stage C", "recurrence_t_category": "T4a(s)", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_3"}]}, {"cancer_type_code": "C06.9", "clinical_n_category": "N0(i-)", "clinical_stage_group": "Stage IIA2", "clinical_t_category": "T2d", "clinical_tumour_staging_system": "Lugano staging system", "date_of_diagnosis": {"month_interval": 30, "day_interval": 900}, "laterality": "Midline", "lymph_nodes_examined_status": "Yes", "number_lymph_nodes_positive": 3, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_2", "specimens": [{"pathological_m_category": "M1d(1)", "pathological_n_category": "N2a", "pathological_stage_group": "Stage L2", "pathological_t_category": "T3e", "pathological_tumour_staging_system": "Ann Arbor staging system", "percent_tumour_cells_measurement_method": "Genomics", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "Unknown", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C18.9", "specimen_collection_date": {"month_interval": 46, "day_interval": 1380}, "specimen_laterality": "Left", "specimen_processing": "Unknown", "specimen_storage": "Frozen in vapour phase", "submitter_specimen_id": "SPECIMEN_4", "tumour_grade": "High", "tumour_grading_system": "Grading system for GISTs", "tumour_histological_type": "8980/9", "sample_registrations": [{"sample_type": "polyA+ RNA", "specimen_tissue_source": "Cervical mucus", "specimen_type": "Primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_9", "tumour_normal_designation": "Normal"}, {"sample_type": "polyA+ RNA", "specimen_tissue_source": "Hydrocele fluid", "specimen_type": "Primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_10"}]}, {"pathological_m_category": "M1d(0)", "pathological_stage_group": "Stage IBES", "pathological_t_category": "Tis", "pathological_tumour_staging_system": "Ann Arbor staging system", "percent_tumour_cells_measurement_method": "Image analysis", "reference_pathology_confirmed_tumour_presence": "Unknown", "specimen_collection_date": {"month_interval": 9, "day_interval": 270}, "specimen_laterality": "Unknown", "specimen_storage": "Not Applicable", "submitter_specimen_id": "SPECIMEN_5", "tumour_grade": "GX", "tumour_grading_system": "Two-tier grading system", "sample_registrations": [{"sample_type": "Total RNA", "specimen_tissue_source": "Urine", "specimen_type": "Normal - tissue adjacent to primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_11", "tumour_normal_designation": "Tumour"}]}, {"pathological_m_category": "M1d(0)", "pathological_n_category": "N0", "pathological_stage_group": "Stage 2B", "pathological_t_category": "T0", "pathological_tumour_staging_system": "Durie-Salmon staging system", "percent_tumour_cells_measurement_method": "Image analysis", "percent_tumour_cells_range": "51-100%", "reference_pathology_confirmed_diagnosis": "Yes", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 3, "day_interval": 90}, "specimen_storage": "Frozen in vapour phase", "submitter_specimen_id": "SPECIMEN_6", "tumour_grade": "Grade III", "tumour_grading_system": "Four-tier grading system", "tumour_histological_type": "8620/9", "sample_registrations": [{"sample_type": "Total DNA", "specimen_type": "Recurrent tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_12"}]}], "treatments": [{"days_per_cycle": 4, "is_primary_treatment": "Yes", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment": "Physician assessed stable disease", "response_to_treatment_criteria_method": "AML Response Criteria", "status_of_treatment": "Patient choice (stopped or interrupted treatment)", "submitter_treatment_id": "TREATMENT_4", "treatment_end_date": {"month_interval": 97, "day_interval": 2910}, "treatment_intent": "Curative", "treatment_setting": "Advanced/Metastatic", "treatment_start_date": {"month_interval": 6, "day_interval": 180}, "treatment_type": ["Chemotherapy", "Stem cell transplant"], "chemotherapies": [{"actual_cumulative_drug_dose": 100, "chemotherapy_drug_dose_units": "mg/m2", "drug_name": "Thalidomide", "drug_reference_identifier": "87354", "prescribed_cumulative_drug_dose": 4600}, {"actual_cumulative_drug_dose": 66, "chemotherapy_drug_dose_units": "ug/m2", "drug_name": "Ponatinib", "prescribed_cumulative_drug_dose": 150}], "followups": [{"date_of_followup": {"month_interval": 12, "day_interval": 360}, "date_of_relapse": {"month_interval": 2, "day_interval": 60}, "disease_status_at_followup": "Stable", "method_of_progression_status": ["Assessment of symptom control (procedure)", "Imaging (procedure)"], "recurrence_m_category": "M1", "recurrence_n_category": "N2a", "recurrence_t_category": "T4", "recurrence_tumour_staging_system": "SEER staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_11"}, {"date_of_followup": {"month_interval": 28, "day_interval": 840}, "date_of_relapse": {"month_interval": 16, "day_interval": 480}, "disease_status_at_followup": "Partial remission", "method_of_progression_status": ["Laboratory data interpretation (procedure)", "Tumor marker measurement (procedure)"], "recurrence_m_category": "M1c(1)", "recurrence_n_category": "N3b", "recurrence_stage_group": "Stage 4", "recurrence_t_category": "Tis pd", "recurrence_tumour_staging_system": "Binet staging system", "submitter_follow_up_id": "FOLLOW_UP_10"}]}, {"is_primary_treatment": "No", "line_of_treatment": 5, "number_of_cycles": 5, "response_to_treatment": "Primary refractory disease", "submitter_treatment_id": "TREATMENT_5", "treatment_end_date": {"month_interval": 92, "day_interval": 2760}, "treatment_start_date": {"month_interval": 39, "day_interval": 1170}, "treatment_type": ["Hormonal therapy", "Surgery"], "chemotherapies": [{"actual_cumulative_drug_dose": 94, "chemotherapy_drug_dose_units": "IU/m2", "drug_name": "Aflibercept", "drug_reference_database": "RxNorm", "drug_reference_identifier": "56438", "prescribed_cumulative_drug_dose": 780}, {"actual_cumulative_drug_dose": 100, "chemotherapy_drug_dose_units": "IU/kg", "drug_name": "Ponatinib", "drug_reference_database": "RxNorm", "drug_reference_identifier": "6534648", "prescribed_cumulative_drug_dose": 4600}], "followups": [{"anatomic_site_progression_or_recurrence": ["C14", "C05"], "date_of_followup": {"month_interval": 26, "day_interval": 780}, "date_of_relapse": {"month_interval": 27, "day_interval": 810}, "disease_status_at_followup": "Stable", "method_of_progression_status": ["Laboratory data interpretation (procedure)", "Assessment of symptom control (procedure)"], "recurrence_m_category": "M1a(1)", "recurrence_n_category": "N0b (no biopsy)", "recurrence_stage_group": "Stage 0a", "recurrence_t_category": "Ta", "recurrence_tumour_staging_system": "FIGO staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_12"}]}, {"days_per_cycle": 6, "is_primary_treatment": "No", "line_of_treatment": 4, "response_to_treatment": "No evidence of disease (NED)", "response_to_treatment_criteria_method": "Blazer score", "status_of_treatment": "Unknown", "submitter_treatment_id": "TREATMENT_6", "treatment_end_date": {"month_interval": 50, "day_interval": 1500}, "treatment_setting": "Locally advanced", "treatment_start_date": {"month_interval": 23, "day_interval": 690}, "treatment_type": ["Surgery"], "chemotherapies": [{"actual_cumulative_drug_dose": 100, "drug_name": "Cladribine", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "836754"}], "followups": [{"anatomic_site_progression_or_recurrence": ["C02", "C04"], "date_of_followup": {"month_interval": 11, "day_interval": 330}, "disease_status_at_followup": "No evidence of disease", "recurrence_m_category": "M1a(1)", "recurrence_n_category": "N0b", "recurrence_stage_group": "Stage IAE", "recurrence_t_category": "TX", "recurrence_tumour_staging_system": "FIGO staging system", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_15"}, {"date_of_followup": {"month_interval": 48, "day_interval": 1440}, "date_of_relapse": {"month_interval": 9, "day_interval": 270}, "method_of_progression_status": ["Assessment of symptom control (procedure)", "Imaging (procedure)"], "recurrence_m_category": "M1d", "recurrence_n_category": "NX", "recurrence_stage_group": "Stage 0a", "recurrence_t_category": "T1a1", "recurrence_tumour_staging_system": "Lugano staging system", "relapse_type": "Biochemical progression", "submitter_follow_up_id": "FOLLOW_UP_14"}]}], "followups": [{"date_of_followup": {"month_interval": 18, "day_interval": 540}, "disease_status_at_followup": "Complete remission", "recurrence_m_category": "M1c(0)", "recurrence_n_category": "N2mi", "recurrence_t_category": "T1b", "recurrence_tumour_staging_system": "Revised International staging system (RISS)", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_13"}]}, {"basis_of_diagnosis": "Unknown", "cancer_type_code": "C34.9", "clinical_n_category": "N0(mol+)", "clinical_stage_group": "Stage IVAS", "clinical_t_category": "T3e", "clinical_tumour_staging_system": "Ann Arbor staging system", "date_of_diagnosis": {"month_interval": 1, "day_interval": 30}, "laterality": "Unilateral, side not specified", "lymph_nodes_examined_method": "Physical palpation of patient", "lymph_nodes_examined_status": "No", "number_lymph_nodes_positive": 8, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_3", "specimens": [{"pathological_stage_group": "In situ", "pathological_t_category": "T1a1", "pathological_tumour_staging_system": "International Neuroblastoma Staging System", "percent_tumour_cells_range": "51-100%", "reference_pathology_confirmed_diagnosis": "Yes", "specimen_anatomic_location": "C43.1", "specimen_collection_date": {"month_interval": 48, "day_interval": 1440}, "specimen_storage": "Unknown", "submitter_specimen_id": "SPECIMEN_7", "tumour_grade": "Grade Group 3", "tumour_grading_system": "Four-tier grading system", "tumour_histological_type": "8820/3", "sample_registrations": [{"sample_type": "Other RNA fractions", "specimen_tissue_source": "Urine", "submitter_sample_id": "SAMPLE_REGISTRATION_13", "tumour_normal_designation": "Tumour"}]}, {"pathological_m_category": "M1a(0)", "pathological_n_category": "N1mi", "pathological_stage_group": "Stage 3", "pathological_t_category": "Ta", "pathological_tumour_staging_system": "FIGO staging system", "percent_tumour_cells_measurement_method": "Unknown", "reference_pathology_confirmed_diagnosis": "Yes", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 36, "day_interval": 1080}, "specimen_laterality": "Left", "specimen_processing": "Cryopreservation - other", "submitter_specimen_id": "SPECIMEN_8", "tumour_grade": "Grade Group 2", "tumour_grading_system": "ISUP grading system", "tumour_histological_type": "8063/1", "sample_registrations": [{"sample_type": "Amplified DNA", "specimen_tissue_source": "Serum", "specimen_type": "Metastatic tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_14", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 7, "is_primary_treatment": "Unknown", "line_of_treatment": 2, "response_to_treatment_criteria_method": "AML Response Criteria", "status_of_treatment": "Not applicable", "submitter_treatment_id": "TREATMENT_7", "treatment_end_date": {"month_interval": 99, "day_interval": 2970}, "treatment_intent": "Forensic", "treatment_setting": "Preventative", "treatment_start_date": {"month_interval": 19, "day_interval": 570}, "chemotherapies": [{"actual_cumulative_drug_dose": 94, "chemotherapy_drug_dose_units": "ug/m2", "drug_name": "Pomalidomide", "drug_reference_database": "PubChem", "drug_reference_identifier": "836494", "prescribed_cumulative_drug_dose": 320}]}, {"days_per_cycle": 7, "is_primary_treatment": "No", "line_of_treatment": 1, "number_of_cycles": 5, "response_to_treatment": "Complete remission", "response_to_treatment_criteria_method": "RECIST 1.1", "submitter_treatment_id": "TREATMENT_8", "treatment_end_date": {"month_interval": 95, "day_interval": 2850}, "treatment_intent": "Supportive", "treatment_setting": "Conditioning", "treatment_start_date": {"month_interval": 32, "day_interval": 960}, "treatment_type": ["Other targeting molecular therapy"], "hormone_therapies": [{"actual_cumulative_drug_dose": 81, "drug_name": "Cabergoline", "hormone_drug_dose_units": "g/m2", "prescribed_cumulative_drug_dose": 142}, {"actual_cumulative_drug_dose": 104, "drug_name": "Estradiol", "drug_reference_identifier": "29875", "hormone_drug_dose_units": "mg/kg", "prescribed_cumulative_drug_dose": 89}, {"actual_cumulative_drug_dose": 110, "drug_name": "Mifepristone", "drug_reference_database": "PubChem", "drug_reference_identifier": "46475", "hormone_drug_dose_units": "g/m2", "prescribed_cumulative_drug_dose": 80}]}, {"days_per_cycle": 7, "is_primary_treatment": "Yes", "line_of_treatment": 5, "number_of_cycles": 4, "response_to_treatment": "Complete remission without measurable residual disease (CR MRD-)", "status_of_treatment": "Other", "submitter_treatment_id": "TREATMENT_9", "treatment_end_date": {"month_interval": 56, "day_interval": 1680}, "treatment_intent": "Guidance", "treatment_setting": "Adjuvant", "treatment_start_date": {"month_interval": 22, "day_interval": 660}, "treatment_type": ["Immunotherapy", "Other targeting molecular therapy"], "hormone_therapies": [{"drug_name": "Lutetium Lu 177 Dotatate", "drug_reference_database": "PubChem", "drug_reference_identifier": "557845", "hormone_drug_dose_units": "IU/kg", "prescribed_cumulative_drug_dose": 86}, {"actual_cumulative_drug_dose": 85, "drug_name": "Desmopressin", "drug_reference_database": "PubChem", "hormone_drug_dose_units": "mg/kg", "prescribed_cumulative_drug_dose": 106}, {"actual_cumulative_drug_dose": 103, "drug_name": "Pasireotide", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "223986", "hormone_drug_dose_units": "ug/m2", "prescribed_cumulative_drug_dose": 154}]}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 56, "comorbidity_treatment": "Surgery", "comorbidity_treatment_status": "No", "comorbidity_type_code": "C43.9", "laterality_of_prior_malignancy": "Right", "prior_malignancy": "Yes"}, {"comorbidity_treatment": "Photodynamic therapy", "comorbidity_treatment_status": "Unknown", "comorbidity_type_code": "C67.6", "prior_malignancy": "Unknown"}, {"age_at_comorbidity_diagnosis": 53, "comorbidity_treatment": "Endoscopic therapy", "comorbidity_treatment_status": "Yes", "comorbidity_type_code": "C34.9", "laterality_of_prior_malignancy": "Unknown", "prior_malignancy": "Yes"}], "exposures": [{"pack_years_smoked": 201, "tobacco_smoking_status": "Current smoker", "tobacco_type": ["Cigar", "Not applicable", "Electronic cigarettes"]}, {"tobacco_smoking_status": "Lifelong non-smoker (<100 cigarettes smoked in lifetime)"}, {"pack_years_smoked": 72, "tobacco_smoking_status": "Current smoker"}], "biomarkers": [{"ca125": 59, "cea": 9, "er_percent_positive": 89.5, "er_status": "Negative", "her2_ihc_status": "Negative", "her2_ish_status": "Cannot be determined", "hpv_ihc_status": "Unknown", "hpv_strain": ["HPV18"], "pr_status": "Negative", "pr_percent_positive": 51.0, "psa_level": 265, "test_date": {"month_interval": 49, "day_interval": 1470}}, {"ca125": 109, "cea": 12, "er_percent_positive": 19.1, "er_status": "Unknown", "her2_ish_status": "Equivocal", "hpv_ihc_status": "Negative", "hpv_pcr_status": "Negative", "pr_status": "Positive", "psa_level": 363, "test_date": {"month_interval": 35, "day_interval": 1050}}, {"ca125": 77, "cea": 11, "er_percent_positive": 57.0, "er_status": "Positive", "her2_ihc_status": "Positive", "her2_ish_status": "Cannot be determined", "hpv_ihc_status": "Cannot be determined", "hpv_pcr_status": "Not applicable", "hpv_strain": ["HPV52", "HPV58", "HPV35"], "pr_percent_positive": 62.7, "psa_level": 201, "test_date": {"month_interval": 50, "day_interval": 1500}}, {"ca125": 111, "cea": 11, "er_percent_positive": 27.2, "er_status": "Not applicable", "her2_ihc_status": "Cannot be determined", "her2_ish_status": "Positive", "hpv_ihc_status": "Negative", "hpv_pcr_status": "Not applicable", "hpv_strain": ["HPV33", "HPV16"], "pr_status": "Cannot be determined", "pr_percent_positive": 96.5, "psa_level": 364, "test_date": {"month_interval": 7, "day_interval": 210}}, {"ca125": 118, "cea": 5, "er_percent_positive": 65.2, "her2_ihc_status": "Unknown", "her2_ish_status": "Positive", "hpv_pcr_status": "Unknown", "pr_status": "Positive", "pr_percent_positive": 59.2, "psa_level": 289, "test_date": {"month_interval": 11, "day_interval": 330}}]}, {"cause_of_death": "Died of other reasons", "date_resolution": "month", "date_of_death": {"month_interval": 25}, "gender": "Non-binary", "is_deceased": true, "primary_site": ["Testis", "Other and unspecified female genital organs", "Other endocrine glands and related structures", "Pancreas"], "program_id": "SYNTHETIC-2", "sex_at_birth": "Female", "submitter_donor_id": "DONOR_10", "primary_diagnoses": [{"basis_of_diagnosis": "Specific tumour markers", "cancer_type_code": "C67.6", "clinical_m_category": "M1a(1)", "clinical_n_category": "N0b (no biopsy)", "clinical_t_category": "TX", "date_of_diagnosis": {"month_interval": 69, "day_interval": 2070}, "laterality": "Right", "lymph_nodes_examined_method": "Imaging", "lymph_nodes_examined_status": "No lymph nodes found in resected specimen", "number_lymph_nodes_positive": 10, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_16", "specimens": [{"pathological_m_category": "M1e", "pathological_n_category": "N0a", "pathological_stage_group": "Stage IIIC", "pathological_t_category": "Tis", "pathological_tumour_staging_system": "AJCC 7th edition", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_tumour_presence": "No", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 20, "day_interval": 600}, "specimen_laterality": "Right", "specimen_processing": "Cryopreservation in liquid nitrogen (dead tissue)", "submitter_specimen_id": "SPECIMEN_22", "tumour_grade": "Low", "tumour_histological_type": "8962/1", "sample_registrations": [{"sample_type": "ctDNA", "specimen_tissue_source": "Fetal blood", "specimen_type": "Normal", "submitter_sample_id": "SAMPLE_REGISTRATION_28", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 2, "is_primary_treatment": "No", "line_of_treatment": 4, "number_of_cycles": 4, "response_to_treatment": "Complete remission with incomplete hematologic recovery (CRi)", "response_to_treatment_criteria_method": "Physician Assessed Response Criteria", "status_of_treatment": "Not applicable", "submitter_treatment_id": "TREATMENT_25", "treatment_end_date": {"month_interval": 87, "day_interval": 2610}, "treatment_setting": "Induction", "treatment_start_date": {"month_interval": 25, "day_interval": 750}, "surgeries": [{"greatest_dimension_tumour": 6, "margin_types_involved": ["Circumferential resection margin", "Proximal margin"], "margin_types_not_involved": ["Distal margin"], "perineural_invasion": "Cannot be assessed", "surgery_location": "Local recurrence", "surgery_site": "C18", "surgery_type": "Laparotomy", "tumour_length": 3, "tumour_width": 6}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C10"], "date_of_followup": {"month_interval": 22, "day_interval": 660}, "disease_status_at_followup": "Relapse or recurrence", "recurrence_stage_group": "Stage IV", "recurrence_t_category": "T1b(m)", "recurrence_tumour_staging_system": "SEER staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_34"}]}]}, {"date_resolution": "month", "program_id": "SYNTHETIC-2", "submitter_donor_id": "DONOR_12", "primary_diagnoses": [{"submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_1a", "specimens": [{"submitter_specimen_id": "SPECIMEN_1a", "sample_registrations": [{"submitter_sample_id": "SAMPLE_REGISTRATION_2a"}, {"submitter_sample_id": "SAMPLE_REGISTRATION_1a"}]}], "treatments": [{"submitter_treatment_id": "TREATMENT_1a", "chemotherapies": [{"drug_name": "Gemcitabine", "drug_reference_database": "NCI Thesaurus"}], "hormone_therapies": [{"actual_cumulative_drug_dose": 85, "prescribed_cumulative_drug_dose": 106}], "immunotherapies": [{"immunotherapy_drug_dose_units": "mg/kg"}], "radiations": [{"anatomical_site_irradiated": "Right Maxilla"}], "surgeries": [{"submitter_specimen_id": "SPECIMEN_1a", "surgery_location": "Metastatic"}], "followups": [{"submitter_follow_up_id": "FOLLOW_UP_2a"}]}, {"submitter_treatment_id": "TREATMENT_2a", "chemotherapies": [{"actual_cumulative_drug_dose": 60}, {"prescribed_cumulative_drug_dose": 4600}], "hormone_therapies": [{"drug_name": "Cabergoline"}, {"drug_name": "Lutetium Lu 177 Dotatate", "drug_reference_identifier": "557845"}], "immunotherapies": [{"immunotherapy_type": "Other immunomodulatory substances"}, {"drug_name": "Nivolumab", "drug_reference_database": "PubChem", "drug_reference_identifier": "987654"}], "radiations": [{"radiation_therapy_type": "Internal"}, {"radiation_therapy_modality": "Teleradiotherapy neutrons (procedure)"}], "surgeries": [{"submitter_specimen_id": "SPECIMEN_1a", "surgery_type": "Wide Local Excision"}, {"submitter_specimen_id": "SPECIMEN_1a", "surgery_site": "C11"}]}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 56, "comorbidity_type_code": "C43.9"}, {"comorbidity_treatment": "Photodynamic therapy"}, {"prior_malignancy": "Yes"}], "exposures": [{"tobacco_smoking_status": "Current smoker"}, {"pack_years_smoked": 72}], "biomarkers": [{"hpv_strain": ["HPV52", "HPV58", "HPV35"]}, {"ca125": 109}, {"test_date": {"month_interval": 49, "day_interval": 1470}}, {"er_status": "Not applicable", "her2_ihc_status": "Cannot be determined", "her2_ish_status": "Positive"}, {"cea": 5}], "followups": [{"submitter_follow_up_id": "FOLLOW_UP_1a"}]}, {"cause_of_death": "Died of other reasons", "date_resolution": "day", "date_of_birth": {"month_interval": -242, "day_interval": -7260}, "date_of_death": {"month_interval": 37, "day_interval": 1110}, "gender": "Woman", "is_deceased": true, "primary_site": ["Thyroid gland", "Kidney"], "program_id": "SYNTHETIC-1", "sex_at_birth": "Unknown", "submitter_donor_id": "DONOR_2", "primary_diagnoses": [{"basis_of_diagnosis": "Cytology", "cancer_type_code": "C43.9", "clinical_m_category": "M0", "clinical_n_category": "N0a (biopsy)", "clinical_t_category": "T3d", "clinical_tumour_staging_system": "AJCC 7th edition", "date_of_diagnosis": {"month_interval": 12, "day_interval": 360}, "laterality": "Unknown", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 12, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_6", "specimens": [{"pathological_n_category": "N1mi", "pathological_stage_group": "Stage IIAS", "pathological_t_category": "T4b", "pathological_tumour_staging_system": "Lugano staging system", "percent_tumour_cells_measurement_method": "Unknown", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "Unknown", "reference_pathology_confirmed_tumour_presence": "Unknown", "specimen_anatomic_location": "C43.9", "specimen_laterality": "Left", "specimen_processing": "Cryopreservation of live cells in liquid nitrogen", "specimen_storage": "Unknown", "submitter_specimen_id": "SPECIMEN_12", "tumour_grade": "Grade Group 4", "tumour_grading_system": "Nuclear grading system for DCIS", "tumour_histological_type": "8830/6", "sample_registrations": [{"specimen_tissue_source": "Female genital fluid", "submitter_sample_id": "SAMPLE_REGISTRATION_18", "tumour_normal_designation": "Normal"}]}], "treatments": [{"days_per_cycle": 1, "is_primary_treatment": "Yes", "number_of_cycles": 3, "status_of_treatment": "Treatment stopped due to acute toxicity", "submitter_treatment_id": "TREATMENT_15", "treatment_intent": "Screening", "treatment_start_date": {"month_interval": 50, "day_interval": 1500}, "immunotherapies": [{"actual_cumulative_drug_dose": 195, "drug_name": "Belantamab", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "4459876", "immunotherapy_drug_dose_units": "mg/kg", "immunotherapy_type": "Other immunomodulatory substances", "prescribed_cumulative_drug_dose": 55}, {"actual_cumulative_drug_dose": 151, "drug_name": "Cotellic", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "239766", "immunotherapy_drug_dose_units": "IU/kg", "immunotherapy_type": "Immune checkpoint inhibitors", "prescribed_cumulative_drug_dose": 89}, {"drug_name": "Lenvatinib", "drug_reference_database": "PubChem", "drug_reference_identifier": "239766", "immunotherapy_drug_dose_units": "IU/m2", "immunotherapy_type": "Monoclonal antibodies other than immune checkpoint inhibitors", "prescribed_cumulative_drug_dose": 146}], "followups": [{"anatomic_site_progression_or_recurrence": ["C12"], "date_of_followup": {"month_interval": 49, "day_interval": 1470}, "date_of_relapse": {"month_interval": 22, "day_interval": 660}, "disease_status_at_followup": "Complete remission", "method_of_progression_status": ["Physical examination procedure (procedure)", "Imaging (procedure)"], "recurrence_m_category": "M0(i+)", "recurrence_stage_group": "Regionalized", "recurrence_t_category": "Tis(Paget's)", "recurrence_tumour_staging_system": "Binet staging system", "submitter_follow_up_id": "FOLLOW_UP_24"}]}, {"days_per_cycle": 4, "is_primary_treatment": "No", "line_of_treatment": 5, "number_of_cycles": 3, "response_to_treatment": "Progressive disease", "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)", "submitter_treatment_id": "TREATMENT_14", "treatment_end_date": {"month_interval": 79, "day_interval": 2370}, "treatment_intent": "Preventive", "treatment_setting": "Salvage", "treatment_start_date": {"month_interval": 8, "day_interval": 240}, "treatment_type": ["Hormonal therapy"], "immunotherapies": [{"drug_name": "Braftovi", "drug_reference_database": "PubChem", "drug_reference_identifier": "987654", "immunotherapy_type": "Other immunomodulatory substances", "prescribed_cumulative_drug_dose": 133}, {"actual_cumulative_drug_dose": 199, "drug_name": "Alunbrig", "drug_reference_database": "PubChem", "drug_reference_identifier": "278936", "immunotherapy_type": "Other immunomodulatory substances", "prescribed_cumulative_drug_dose": 174}, {"actual_cumulative_drug_dose": 90, "drug_name": "Nivolumab", "drug_reference_database": "PubChem", "drug_reference_identifier": "987654", "immunotherapy_drug_dose_units": "g/m2", "immunotherapy_type": "Cell-based", "prescribed_cumulative_drug_dose": 55}]}], "followups": [{"date_of_followup": {"month_interval": 15, "day_interval": 450}, "date_of_relapse": {"month_interval": 6, "day_interval": 180}, "disease_status_at_followup": "Relapse or recurrence", "recurrence_m_category": "M1d", "recurrence_n_category": "N3", "recurrence_stage_group": "Stage IIBES", "recurrence_t_category": "T2a", "recurrence_tumour_staging_system": "FIGO staging system", "relapse_type": "Local recurrence and distant metastasis", "submitter_follow_up_id": "FOLLOW_UP_23"}]}, {"basis_of_diagnosis": "Clinical investigation", "cancer_type_code": "C18.9", "clinical_m_category": "M1a(0)", "clinical_n_category": "NX", "clinical_stage_group": "Stage L1", "clinical_t_category": "T2(s)", "clinical_tumour_staging_system": "Lugano staging system", "date_of_diagnosis": {"month_interval": 64, "day_interval": 1920}, "laterality": "Unilateral, side not specified", "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4", "specimens": [{"pathological_m_category": "M1b(1)", "pathological_n_category": "N0a (biopsy)", "pathological_stage_group": "Stage IIIBS", "pathological_t_category": "Tis(DCIS)", "pathological_tumour_staging_system": "Durie-Salmon staging system", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C34.9", "specimen_collection_date": {"month_interval": 27, "day_interval": 810}, "specimen_laterality": "Unknown", "specimen_processing": "Cryopreservation - other", "specimen_storage": "Not Applicable", "submitter_specimen_id": "SPECIMEN_9", "tumour_grade": "Low", "tumour_grading_system": "Two-tier grading system", "tumour_histological_type": "8980/9", "sample_registrations": [{"sample_type": "Other DNA enrichments", "specimen_tissue_source": "Vitreous fluid", "submitter_sample_id": "SAMPLE_REGISTRATION_15", "tumour_normal_designation": "Normal"}]}, {"pathological_m_category": "M1b(1)", "pathological_n_category": "N0b", "pathological_stage_group": "Stage M", "pathological_tumour_staging_system": "Revised International staging system (RISS)", "percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei", "percent_tumour_cells_range": "51-100%", "reference_pathology_confirmed_diagnosis": "Yes", "specimen_anatomic_location": "C43.1", "specimen_collection_date": {"month_interval": 7, "day_interval": 210}, "specimen_laterality": "Left", "specimen_processing": "Cryopreservation in liquid nitrogen (dead tissue)", "specimen_storage": "Frozen in -70 freezer", "submitter_specimen_id": "SPECIMEN_10", "tumour_grade": "Grade Group 2", "tumour_grading_system": "Grading system for GNETs", "tumour_histological_type": "8063/1", "sample_registrations": [{"sample_type": "polyA+ RNA", "specimen_tissue_source": "Renal cyst fluid", "submitter_sample_id": "SAMPLE_REGISTRATION_16", "tumour_normal_designation": "Normal"}]}], "treatments": [{"days_per_cycle": 4, "is_primary_treatment": "Yes", "response_to_treatment": "Major response", "response_to_treatment_criteria_method": "Blazer score", "status_of_treatment": "Physician decision (stopped or interrupted treatment)", "submitter_treatment_id": "TREATMENT_11", "treatment_end_date": {"month_interval": 90, "day_interval": 2700}, "treatment_intent": "Diagnostic", "treatment_setting": "Induction", "treatment_start_date": {"month_interval": 42, "day_interval": 1260}, "hormone_therapies": [{"drug_name": "Bromocriptine", "drug_reference_identifier": "223986", "hormone_drug_dose_units": "mg/kg"}, {"actual_cumulative_drug_dose": 150, "drug_name": "Dienogest", "drug_reference_identifier": "84857"}]}, {"days_per_cycle": 5, "is_primary_treatment": "No", "number_of_cycles": 4, "response_to_treatment": "Complete remission", "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)", "status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)", "submitter_treatment_id": "TREATMENT_10", "treatment_end_date": {"month_interval": 56, "day_interval": 1680}, "treatment_intent": "Forensic", "treatment_setting": "Locally advanced", "treatment_start_date": {"month_interval": 49, "day_interval": 1470}, "treatment_type": ["Immunotherapy", "Stem cell transplant", "No treatment"], "hormone_therapies": [{"drug_name": "Etonogestrel", "drug_reference_database": "PubChem", "prescribed_cumulative_drug_dose": 186}, {"actual_cumulative_drug_dose": 127, "drug_name": "Tamoxifen", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "46475", "hormone_drug_dose_units": "IU/m2", "prescribed_cumulative_drug_dose": 73}, {"actual_cumulative_drug_dose": 178, "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "84857", "hormone_drug_dose_units": "ug/m2", "prescribed_cumulative_drug_dose": 125}]}]}, {"basis_of_diagnosis": "Clinical investigation", "cancer_type_code": "C67.6", "clinical_n_category": "N3b", "clinical_stage_group": "Stage I", "clinical_t_category": "Tis(LCIS)", "clinical_tumour_staging_system": "AJCC 6th edition", "date_of_diagnosis": {"month_interval": 64, "day_interval": 1920}, "laterality": "Not a paired site", "lymph_nodes_examined_method": "Imaging", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 14, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_5", "specimens": [{"pathological_m_category": "M0(i+)", "pathological_n_category": "N1a(sn)", "pathological_stage_group": "Stage IIIBES", "pathological_t_category": "T1c", "pathological_tumour_staging_system": "SEER staging system", "percent_tumour_cells_range": "20-50%", "reference_pathology_confirmed_diagnosis": "Unknown", "reference_pathology_confirmed_tumour_presence": "No", "specimen_anatomic_location": "C43.1", "specimen_collection_date": {"month_interval": 35, "day_interval": 1050}, "specimen_laterality": "Not applicable", "specimen_processing": "Cryopreservation in dry ice (dead tissue)", "specimen_storage": "Cut slide", "submitter_specimen_id": "SPECIMEN_11", "tumour_grade": "G3", "tumour_grading_system": "Two-tier grading system", "tumour_histological_type": "8289/9", "sample_registrations": [{"sample_type": "polyA+ RNA", "specimen_tissue_source": "Bone marrow fluid", "specimen_type": "Xenograft - derived from primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_17", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 2, "is_primary_treatment": "Yes", "line_of_treatment": 5, "number_of_cycles": 4, "response_to_treatment": "Immune uncomfirmed progressive disease (iUPD)", "response_to_treatment_criteria_method": "Physician Assessed Response Criteria", "submitter_treatment_id": "TREATMENT_13", "treatment_end_date": {"month_interval": 57, "day_interval": 1710}, "treatment_intent": "Guidance", "treatment_setting": "Preventative", "treatment_start_date": {"month_interval": 16, "day_interval": 480}, "treatment_type": ["Surgery"], "hormone_therapies": [{"actual_cumulative_drug_dose": 156, "drug_name": "Octreotide", "drug_reference_database": "RxNorm", "drug_reference_identifier": "345678", "hormone_drug_dose_units": "mg/kg", "prescribed_cumulative_drug_dose": 53}]}, {"days_per_cycle": 3, "is_primary_treatment": "Yes", "number_of_cycles": 5, "response_to_treatment": "Major response", "response_to_treatment_criteria_method": "iRECIST", "status_of_treatment": "Treatment incomplete due to technical or organizational problems", "submitter_treatment_id": "TREATMENT_12", "treatment_end_date": {"month_interval": 65, "day_interval": 1950}, "treatment_intent": "Forensic", "treatment_setting": "Locally advanced", "treatment_start_date": {"month_interval": 44, "day_interval": 1320}, "treatment_type": ["Chemotherapy"], "hormone_therapies": [{"drug_name": "Aminoglutethimide", "drug_reference_database": "RxNorm", "drug_reference_identifier": "84857", "hormone_drug_dose_units": "mg/kg", "prescribed_cumulative_drug_dose": 175}, {"actual_cumulative_drug_dose": 79, "drug_reference_database": "PubChem", "hormone_drug_dose_units": "ug/m2", "prescribed_cumulative_drug_dose": 88}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C18"], "date_of_followup": {"month_interval": 17, "day_interval": 510}, "date_of_relapse": {"month_interval": 17, "day_interval": 510}, "disease_status_at_followup": "Partial remission", "recurrence_m_category": "M1a", "recurrence_stage_group": "Stage IIBE", "recurrence_t_category": "T1a", "recurrence_tumour_staging_system": "AJCC 8th edition", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_19"}, {"method_of_progression_status": ["Physical examination procedure (procedure)"], "recurrence_m_category": "M0", "recurrence_t_category": "Tis pu", "recurrence_tumour_staging_system": "Rai staging system", "relapse_type": "Local recurrence", "submitter_follow_up_id": "FOLLOW_UP_22"}, {"date_of_followup": {"month_interval": 47, "day_interval": 1410}, "date_of_relapse": {"month_interval": 49, "day_interval": 1470}, "disease_status_at_followup": "No evidence of disease", "recurrence_m_category": "M1d(1)", "recurrence_n_category": "N2c", "recurrence_t_category": "T4e", "recurrence_tumour_staging_system": "Revised International staging system (RISS)", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_21"}, {"date_of_followup": {"month_interval": 5, "day_interval": 150}, "date_of_relapse": {"month_interval": 21, "day_interval": 630}, "recurrence_stage_group": "Stage IBS", "recurrence_t_category": "T4b(s)", "recurrence_tumour_staging_system": "SEER staging system", "relapse_type": "Biochemical progression", "submitter_follow_up_id": "FOLLOW_UP_20"}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 42, "comorbidity_treatment": "Bone marrow transplant", "comorbidity_treatment_status": "Unknown", "comorbidity_type_code": "C02.0", "prior_malignancy": "No"}, {"age_at_comorbidity_diagnosis": 54, "comorbidity_treatment": "Radiation therapy", "comorbidity_treatment_status": "Unknown", "comorbidity_type_code": "C03.9"}, {"age_at_comorbidity_diagnosis": 42, "comorbidity_treatment": "Bone marrow transplant", "comorbidity_treatment_status": "Yes", "comorbidity_type_code": "C34.9", "prior_malignancy": "Unknown"}], "exposures": [{"tobacco_smoking_status": "Lifelong non-smoker (<100 cigarettes smoked in lifetime)"}, {"pack_years_smoked": 111, "tobacco_smoking_status": "Current reformed smoker for <= 15 years"}], "biomarkers": [{"ca125": 80, "cea": 12, "er_percent_positive": 30.1, "her2_ihc_status": "Positive", "her2_ish_status": "Negative", "hpv_ihc_status": "Cannot be determined", "hpv_pcr_status": "Not applicable", "hpv_strain": ["HPV16"], "pr_status": "Negative", "pr_percent_positive": 57.8, "psa_level": 321, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4", "test_date": {"month_interval": 31, "day_interval": 930}}, {"ca125": 110, "cea": 6, "er_percent_positive": 18.5, "er_status": "Unknown", "her2_ihc_status": "Negative", "her2_ish_status": "Unknown", "hpv_pcr_status": "Unknown", "hpv_strain": ["HPV73"], "pr_status": "Negative", "pr_percent_positive": 86.0, "psa_level": 365, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4", "test_date": {"month_interval": 35, "day_interval": 1050}}, {"ca125": 29, "cea": 10, "er_percent_positive": 80.2, "er_status": "Not applicable", "her2_ihc_status": "Positive", "her2_ish_status": "Unknown", "hpv_ihc_status": "Unknown", "hpv_pcr_status": "Not applicable", "hpv_strain": ["HPV66", "HPV59", "HPV39"], "pr_status": "Positive", "pr_percent_positive": 29.9, "psa_level": 263, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4", "test_date": {"month_interval": 28, "day_interval": 840}}, {"ca125": 90, "cea": 8, "er_percent_positive": 1.7, "er_status": "Negative", "her2_ihc_status": "Cannot be determined", "hpv_pcr_status": "Unknown", "pr_status": "Not applicable", "pr_percent_positive": 40.8, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_4", "test_date": {"month_interval": 32, "day_interval": 960}}]}, {"cause_of_death": "Unknown", "date_resolution": "month", "date_of_birth": {"month_interval": -483}, "date_of_death": {"month_interval": 33}, "gender": "Man", "is_deceased": true, "primary_site": ["Parotid gland", "Rectum", "Skin"], "program_id": "SYNTHETIC-1", "sex_at_birth": "Female", "submitter_donor_id": "DONOR_3", "primary_diagnoses": [{"basis_of_diagnosis": "Cytology", "clinical_m_category": "M1c(0)", "clinical_n_category": "N1c", "clinical_stage_group": "Stage IES", "clinical_t_category": "T4b(s)", "date_of_diagnosis": {"month_interval": 81, "day_interval": 2430}, "laterality": "Unknown", "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 6, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_7", "specimens": [{"pathological_n_category": "N0a", "pathological_stage_group": "Stage 4S", "pathological_t_category": "T1b(m)", "pathological_tumour_staging_system": "FIGO staging system", "percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "Yes", "reference_pathology_confirmed_tumour_presence": "Yes", "specimen_anatomic_location": "C67.6", "specimen_collection_date": {"month_interval": 30, "day_interval": 900}, "specimen_processing": "Formalin fixed & paraffin embedded", "submitter_specimen_id": "SPECIMEN_13", "tumour_grading_system": "Grading system for GISTs", "sample_registrations": [{"sample_type": "Other RNA fractions", "specimen_tissue_source": "Cerebrospinal fluid", "specimen_type": "Metastatic tumour - metastasis local to lymph node", "submitter_sample_id": "SAMPLE_REGISTRATION_19", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 2, "is_primary_treatment": "Unknown", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment_criteria_method": "iRECIST", "status_of_treatment": "Treatment incomplete because patient died", "submitter_treatment_id": "TREATMENT_16", "treatment_end_date": {"month_interval": 86, "day_interval": 2580}, "treatment_intent": "Supportive", "treatment_setting": "Induction", "treatment_start_date": {"month_interval": 22, "day_interval": 660}, "treatment_type": ["Immunotherapy"], "immunotherapies": [{"actual_cumulative_drug_dose": 104, "drug_name": "Kadcyla", "drug_reference_database": "RxNorm", "drug_reference_identifier": "987654", "immunotherapy_drug_dose_units": "ug/m2", "immunotherapy_type": "Cell-based"}, {"actual_cumulative_drug_dose": 91, "drug_name": "Niraparib", "drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "278936", "immunotherapy_drug_dose_units": "g/m2", "prescribed_cumulative_drug_dose": 53}], "followups": [{"anatomic_site_progression_or_recurrence": ["C09", "C02"], "date_of_followup": {"month_interval": 24, "day_interval": 720}, "date_of_relapse": {"month_interval": 35, "day_interval": 1050}, "disease_status_at_followup": "No evidence of disease", "method_of_progression_status": ["Assessment of symptom control (procedure)", "Tumor marker measurement (procedure)"], "recurrence_m_category": "M1b", "recurrence_n_category": "N0b (no biopsy)", "recurrence_stage_group": "Stage 4", "recurrence_t_category": "T1", "recurrence_tumour_staging_system": "Durie-Salmon staging system", "submitter_follow_up_id": "FOLLOW_UP_25"}]}]}, {"basis_of_diagnosis": "Cytology", "cancer_type_code": "C67.6", "clinical_m_category": "M0", "clinical_n_category": "N2", "clinical_stage_group": "Stage IIBS", "clinical_t_category": "TX", "clinical_tumour_staging_system": "Revised International staging system (RISS)", "date_of_diagnosis": {"month_interval": 21, "day_interval": 630}, "laterality": "Left", "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "number_lymph_nodes_positive": 12, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_8", "specimens": [{"pathological_m_category": "M1b(1)", "pathological_n_category": "N1a", "pathological_stage_group": "Stage IIBS", "pathological_t_category": "T3a", "pathological_tumour_staging_system": "Lugano staging system", "percent_tumour_cells_measurement_method": "Genomics", "percent_tumour_cells_range": "20-50%", "reference_pathology_confirmed_diagnosis": "Unknown", "reference_pathology_confirmed_tumour_presence": "Yes", "specimen_collection_date": {"month_interval": 31, "day_interval": 930}, "specimen_processing": "Other", "specimen_storage": "RNA later frozen", "submitter_specimen_id": "SPECIMEN_14", "tumour_grade": "G4", "tumour_grading_system": "Scarff-Bloom-Richardson grading system", "tumour_histological_type": "8240/1", "sample_registrations": [{"sample_type": "polyA+ RNA", "specimen_tissue_source": "Bone marrow fluid", "specimen_type": "Primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_20", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 5, "is_primary_treatment": "No", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment": "Immune confirmed progressive disease (iCPD)", "response_to_treatment_criteria_method": "Blazer score", "status_of_treatment": "Other", "submitter_treatment_id": "TREATMENT_17", "treatment_end_date": {"month_interval": 52, "day_interval": 1560}, "treatment_intent": "Screening", "treatment_setting": "Preventative", "treatment_start_date": {"month_interval": 34, "day_interval": 1020}, "immunotherapies": [{"drug_name": "Pembrolizumab", "drug_reference_database": "RxNorm", "drug_reference_identifier": "8756456", "immunotherapy_drug_dose_units": "cells/kg", "immunotherapy_type": "Other immunomodulatory substances", "prescribed_cumulative_drug_dose": 153}, {"actual_cumulative_drug_dose": 164, "drug_name": "Obinutuzumab", "drug_reference_database": "RxNorm", "drug_reference_identifier": "239766", "immunotherapy_drug_dose_units": "cells/kg", "immunotherapy_type": "Cell-based", "prescribed_cumulative_drug_dose": 108}], "followups": [{"anatomic_site_progression_or_recurrence": ["C15", "C13"], "date_of_followup": {"month_interval": 33, "day_interval": 990}, "date_of_relapse": {"month_interval": 45, "day_interval": 1350}, "disease_status_at_followup": "Partial remission", "method_of_progression_status": ["Laboratory data interpretation (procedure)", "Imaging (procedure)"], "recurrence_m_category": "M1a(1)", "recurrence_n_category": "N0(mol-)", "recurrence_stage_group": "Stage IIS", "recurrence_t_category": "T2a2", "submitter_follow_up_id": "FOLLOW_UP_26"}]}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 36, "comorbidity_treatment": "Chemotherapy", "comorbidity_treatment_status": "No", "comorbidity_type_code": "C03.9", "prior_malignancy": "No"}, {"age_at_comorbidity_diagnosis": 48, "comorbidity_treatment": "Ablation", "comorbidity_treatment_status": "Yes", "comorbidity_type_code": "C04.9", "laterality_of_prior_malignancy": "Bilateral", "prior_malignancy": "Yes"}], "exposures": [{"tobacco_smoking_status": "Lifelong non-smoker (<100 cigarettes smoked in lifetime)"}], "biomarkers": [{"cea": 4, "er_percent_positive": 40.7, "her2_ihc_status": "Not applicable", "her2_ish_status": "Positive", "hpv_ihc_status": "Cannot be determined", "hpv_strain": ["HPV18", "HPV66", "HPV52"], "pr_status": "Unknown", "pr_percent_positive": 23.2, "psa_level": 325, "submitter_specimen_id": "SPECIMEN_13", "test_date": {"month_interval": 50, "day_interval": 1500}}, {"ca125": 121, "cea": 10, "er_percent_positive": 10.5, "er_status": "Cannot be determined", "her2_ihc_status": "Positive", "her2_ish_status": "Cannot be determined", "hpv_ihc_status": "Unknown", "hpv_strain": ["HPV18"], "pr_status": "Negative", "pr_percent_positive": 59.4, "psa_level": 354, "submitter_specimen_id": "SPECIMEN_13", "test_date": {"month_interval": 19, "day_interval": 570}}, {"ca125": 83, "cea": 6, "er_percent_positive": 89.3, "her2_ihc_status": "Negative", "her2_ish_status": "Cannot be determined", "hpv_ihc_status": "Cannot be determined", "hpv_pcr_status": "Negative", "hpv_strain": ["HPV35", "HPV45"], "pr_status": "Not applicable", "pr_percent_positive": 65.8, "psa_level": 262, "submitter_specimen_id": "SPECIMEN_13", "test_date": {"month_interval": 31, "day_interval": 930}}]}, {"date_resolution": "month", "date_alive_after_lost_to_followup": {"month_interval": 1}, "date_of_birth": {"month_interval": -964}, "gender": "Man", "primary_site": ["Ovary"], "program_id": "SYNTHETIC-1", "submitter_donor_id": "DONOR_4", "primary_diagnoses": [{"basis_of_diagnosis": "Histology of a metastasis", "cancer_type_code": "C02.1", "clinical_m_category": "M1c(0)", "clinical_n_category": "N3b", "clinical_stage_group": "Stage IBE", "clinical_t_category": "T2a1", "clinical_tumour_staging_system": "AJCC 6th edition", "date_of_diagnosis": {"month_interval": 43, "day_interval": 1290}, "laterality": "Left", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 14, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_10", "specimens": [{"pathological_m_category": "M1b(0)", "pathological_t_category": "T4c", "pathological_tumour_staging_system": "Rai staging system", "percent_tumour_cells_range": "20-50%", "reference_pathology_confirmed_diagnosis": "Not done", "reference_pathology_confirmed_tumour_presence": "No", "specimen_anatomic_location": "C34.9", "specimen_collection_date": {"month_interval": 19, "day_interval": 570}, "specimen_laterality": "Unknown", "specimen_processing": "Unknown", "specimen_storage": "Paraffin block", "submitter_specimen_id": "SPECIMEN_16", "tumour_grade": "Low", "tumour_grading_system": "FNCLCC grading system", "tumour_histological_type": "8973/2", "sample_registrations": [{"sample_type": "Total DNA", "specimen_tissue_source": "Blood derived - bone marrow", "specimen_type": "Normal", "submitter_sample_id": "SAMPLE_REGISTRATION_22", "tumour_normal_designation": "Normal"}]}], "treatments": [{"days_per_cycle": 4, "is_primary_treatment": "No", "line_of_treatment": 1, "number_of_cycles": 5, "response_to_treatment": "Physician assessed stable disease", "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria", "status_of_treatment": "Other", "submitter_treatment_id": "TREATMENT_19", "treatment_end_date": {"month_interval": 63, "day_interval": 1890}, "treatment_intent": "Guidance", "treatment_setting": "Locally advanced", "treatment_start_date": {"month_interval": 7, "day_interval": 210}, "treatment_type": ["Chemotherapy"], "radiations": [{"anatomical_site_irradiated": "Boost - Area Previously Treated", "radiation_therapy_dosage": 66, "radiation_therapy_fractions": 35, "radiation_therapy_type": "Internal"}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C02", "C10"], "date_of_followup": {"month_interval": 45, "day_interval": 1350}, "date_of_relapse": {"month_interval": 43, "day_interval": 1290}, "disease_status_at_followup": "Stable", "recurrence_n_category": "N0b (no biopsy)", "recurrence_stage_group": "Stage 2A", "recurrence_t_category": "Tis(LAMN)", "recurrence_tumour_staging_system": "SEER staging system", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_28"}]}, {"basis_of_diagnosis": "Cytology", "cancer_type_code": "C43.9", "clinical_m_category": "M0", "clinical_n_category": "N2b", "clinical_stage_group": "Stage IIIA", "clinical_t_category": "T4a(s)", "date_of_diagnosis": {"month_interval": 30, "day_interval": 900}, "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "lymph_nodes_examined_status": "Yes", "number_lymph_nodes_positive": 4, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_9", "specimens": [{"pathological_n_category": "N3b", "pathological_t_category": "T1b(m)", "pathological_tumour_staging_system": "SEER staging system", "percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei", "reference_pathology_confirmed_diagnosis": "Yes", "reference_pathology_confirmed_tumour_presence": "Yes", "specimen_anatomic_location": "C64.9", "specimen_collection_date": {"month_interval": 44, "day_interval": 1320}, "specimen_laterality": "Right", "specimen_processing": "Fresh", "specimen_storage": "Unknown", "submitter_specimen_id": "SPECIMEN_15", "tumour_grade": "Grade 2", "tumour_grading_system": "Scarff-Bloom-Richardson grading system", "tumour_histological_type": "8830/6", "sample_registrations": [{"sample_type": "Amplified DNA", "specimen_type": "Metastatic tumour - metastasis to distant location", "submitter_sample_id": "SAMPLE_REGISTRATION_21", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 6, "line_of_treatment": 1, "response_to_treatment_criteria_method": "RECIST 1.1", "status_of_treatment": "Unknown", "submitter_treatment_id": "TREATMENT_18", "treatment_intent": "Forensic", "treatment_start_date": {"month_interval": 36, "day_interval": 1080}, "immunotherapies": [{"drug_reference_database": "NCI Thesaurus", "drug_reference_identifier": "8756456", "immunotherapy_drug_dose_units": "IU/kg", "prescribed_cumulative_drug_dose": 77}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C19"], "date_of_followup": {"month_interval": 37, "day_interval": 1110}, "date_of_relapse": {"month_interval": 46, "day_interval": 1380}, "disease_status_at_followup": "Distant progression", "recurrence_m_category": "M1d(1)", "recurrence_n_category": "N2c", "recurrence_t_category": "T2c", "recurrence_tumour_staging_system": "FIGO staging system", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_27"}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 60, "comorbidity_treatment": "Other targeting molecular therapy", "comorbidity_treatment_status": "No", "comorbidity_type_code": "C02.9"}, {"comorbidity_treatment": "No treatment", "comorbidity_type_code": "C43.9", "prior_malignancy": "No"}], "biomarkers": [{"cea": 12, "er_status": "Not applicable", "her2_ihc_status": "Positive", "her2_ish_status": "Cannot be determined", "hpv_ihc_status": "Cannot be determined", "hpv_pcr_status": "Cannot be determined", "hpv_strain": ["HPV66", "HPV56"], "pr_status": "Unknown", "pr_percent_positive": 41.9, "psa_level": 318, "submitter_treatment_id": "TREATMENT_15", "test_date": {"month_interval": 20, "day_interval": 600}}, {"ca125": 81, "cea": 12, "er_percent_positive": 59.2, "er_status": "Unknown", "her2_ihc_status": "Cannot be determined", "her2_ish_status": "Not applicable", "hpv_ihc_status": "Not applicable", "hpv_pcr_status": "Unknown", "hpv_strain": ["HPV56", "HPV45", "HPV59"], "pr_status": "Positive", "pr_percent_positive": 82.4, "psa_level": 249, "submitter_treatment_id": "TREATMENT_15", "test_date": {"month_interval": 45, "day_interval": 1350}}]}, {"date_resolution": "day", "date_of_birth": {"month_interval": -641, "day_interval": -19230}, "gender": "Woman", "primary_site": ["Cervix uteri", "Vulva"], "program_id": "SYNTHETIC-1", "submitter_donor_id": "DONOR_5", "primary_diagnoses": [{"basis_of_diagnosis": "Clinical investigation", "cancer_type_code": "C43.9", "clinical_m_category": "M1d(0)", "clinical_stage_group": "Stage IS", "clinical_t_category": "Tis(LCIS)", "clinical_tumour_staging_system": "AJCC 7th edition", "date_of_diagnosis": {"month_interval": 70, "day_interval": 2100}, "laterality": "Left", "lymph_nodes_examined_method": "Imaging", "lymph_nodes_examined_status": "Yes", "number_lymph_nodes_positive": 9, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_11", "specimens": [{"pathological_m_category": "M1e", "pathological_n_category": "NX", "pathological_stage_group": "Stage III", "pathological_t_category": "Tis pd", "pathological_tumour_staging_system": "Lugano staging system", "percent_tumour_cells_measurement_method": "Genomics", "percent_tumour_cells_range": "51-100%", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C34.9", "specimen_collection_date": {"month_interval": 16, "day_interval": 480}, "specimen_laterality": "Left", "specimen_processing": "Fresh", "specimen_storage": "Other", "submitter_specimen_id": "SPECIMEN_17", "tumour_grade": "Grade Group 5", "tumour_grading_system": "Two-tier grading system", "tumour_histological_type": "8250/3", "sample_registrations": [{"sample_type": "Other DNA enrichments", "specimen_tissue_source": "Bone marrow fluid", "specimen_type": "Normal - tissue adjacent to primary tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_23", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 7, "is_primary_treatment": "Yes", "line_of_treatment": 1, "number_of_cycles": 4, "response_to_treatment": "Physician assessed complete response", "response_to_treatment_criteria_method": "Response Assessment in Neuro-Oncology (RANO)", "status_of_treatment": "Patient choice (stopped or interrupted treatment)", "submitter_treatment_id": "TREATMENT_20", "treatment_end_date": {"month_interval": 91, "day_interval": 2730}, "treatment_type": ["Bone marrow transplant", "Photodynamic therapy"], "radiations": [{"anatomical_site_irradiated": "Right Maxilla", "radiation_boost": true, "radiation_therapy_dosage": 70, "radiation_therapy_fractions": 35, "radiation_therapy_modality": "Teleradiotherapy neutrons (procedure)", "radiation_therapy_type": "Internal", "reference_radiation_treatment_id": "REFERENCE_RADIATION_TREATMENT_2"}], "followups": [{"date_of_followup": {"month_interval": 15, "day_interval": 450}, "disease_status_at_followup": "Loco-regional progression", "method_of_progression_status": ["Imaging (procedure)", "Assessment of symptom control (procedure)"], "recurrence_m_category": "M1b(0)", "recurrence_n_category": "N3a", "recurrence_stage_group": "Stage IVES", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_29"}]}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 39, "comorbidity_treatment": "Other targeting molecular therapy", "comorbidity_treatment_status": "Yes", "prior_malignancy": "No"}]}, {"cause_of_death": "Died of cancer", "date_resolution": "day", "date_of_birth": {"month_interval": -575, "day_interval": -17250}, "date_of_death": {"month_interval": 67, "day_interval": 2010}, "is_deceased": true, "primary_site": ["Ovary", "Stomach"], "program_id": "SYNTHETIC-1", "submitter_donor_id": "DONOR_6", "primary_diagnoses": [{"basis_of_diagnosis": "Clinical", "cancer_type_code": "C04.0", "clinical_m_category": "M1b(0)", "clinical_n_category": "N1a(sn)", "clinical_t_category": "T1a1", "clinical_tumour_staging_system": "SEER staging system", "date_of_diagnosis": {"month_interval": 20, "day_interval": 600}, "laterality": "Not a paired site", "lymph_nodes_examined_method": "Imaging", "lymph_nodes_examined_status": "Cannot be determined", "number_lymph_nodes_positive": 8, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_12", "specimens": [{"pathological_m_category": "M1d", "pathological_stage_group": "Stage IIIC", "pathological_t_category": "T2", "pathological_tumour_staging_system": "AJCC 6th edition", "percent_tumour_cells_measurement_method": "Genomics", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "Yes", "specimen_anatomic_location": "C64.9", "specimen_collection_date": {"month_interval": 23, "day_interval": 690}, "specimen_processing": "Cryopreservation in liquid nitrogen (dead tissue)", "specimen_storage": "Frozen in -70 freezer", "submitter_specimen_id": "SPECIMEN_18", "tumour_grade": "Low grade", "tumour_grading_system": "IASLC grading system", "tumour_histological_type": "8973/2", "sample_registrations": [{"sample_type": "Total RNA", "specimen_tissue_source": "Blood derived - bone marrow", "specimen_type": "Cell line - derived from xenograft tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_24", "tumour_normal_designation": "Normal"}]}], "treatments": [{"days_per_cycle": 5, "is_primary_treatment": "No", "line_of_treatment": 3, "number_of_cycles": 5, "response_to_treatment": "No evidence of disease (NED)", "response_to_treatment_criteria_method": "Blazer score", "status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)", "submitter_treatment_id": "TREATMENT_21", "treatment_end_date": {"month_interval": 56, "day_interval": 1680}, "treatment_intent": "Forensic", "treatment_setting": "Preventative", "treatment_start_date": {"month_interval": 23, "day_interval": 690}, "treatment_type": ["No treatment", "Other targeting molecular therapy", "Surgery"], "radiations": [{"anatomical_site_irradiated": "Bilateral Hip", "radiation_therapy_dosage": 70, "radiation_therapy_fractions": 35, "radiation_therapy_modality": "Teleradiotherapy using electrons (procedure)"}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C15"], "date_of_followup": {"month_interval": 46, "day_interval": 1380}, "disease_status_at_followup": "Relapse or recurrence", "method_of_progression_status": ["Assessment of symptom control (procedure)", "Laboratory data interpretation (procedure)"], "recurrence_m_category": "MX", "recurrence_n_category": "N0(mol+)", "recurrence_stage_group": "Stage 4", "recurrence_t_category": "T2", "recurrence_tumour_staging_system": "Durie-Salmon staging system", "relapse_type": "Progression (liquid tumours)", "submitter_follow_up_id": "FOLLOW_UP_30"}]}], "comorbidities": [{"comorbidity_treatment": "Radiation therapy", "comorbidity_type_code": "C02.2", "laterality_of_prior_malignancy": "Not applicable", "prior_malignancy": "Yes"}]}, {"cause_of_death": "Unknown", "date_resolution": "day", "date_of_birth": {"month_interval": -138, "day_interval": -4140}, "date_of_death": {"month_interval": 27, "day_interval": 810}, "gender": "Woman", "is_deceased": true, "primary_site": ["Other and unspecified major salivary glands", "Other and unspecified parts of biliary tract", "Base of tongue", "Hypopharynx", "Skin"], "program_id": "SYNTHETIC-2", "sex_at_birth": "Male", "submitter_donor_id": "DONOR_7", "primary_diagnoses": [{"clinical_m_category": "M1d(1)", "clinical_n_category": "N0a", "clinical_stage_group": "Stage II bulky", "clinical_t_category": "TX", "clinical_tumour_staging_system": "AJCC 6th edition", "date_of_diagnosis": {"month_interval": 25, "day_interval": 750}, "laterality": "Bilateral", "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "lymph_nodes_examined_status": "Not applicable", "number_lymph_nodes_positive": 15, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_13", "specimens": [{"pathological_m_category": "M1e", "pathological_n_category": "N2mi", "pathological_stage_group": "Stage 1", "pathological_t_category": "T4a(s)", "pathological_tumour_staging_system": "FIGO staging system", "percent_tumour_cells_range": "20-50%", "reference_pathology_confirmed_tumour_presence": "Unknown", "specimen_anatomic_location": "C43.9", "specimen_collection_date": {"month_interval": 16, "day_interval": 480}, "specimen_processing": "Other", "specimen_storage": "Paraffin block", "submitter_specimen_id": "SPECIMEN_19", "tumour_grading_system": "Two-tier grading system", "sample_registrations": [{"specimen_tissue_source": "Cervical mucus", "specimen_type": "Recurrent tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_25", "tumour_normal_designation": "Tumour"}]}], "treatments": [{"days_per_cycle": 6, "is_primary_treatment": "No", "number_of_cycles": 5, "response_to_treatment": "Immune uncomfirmed progressive disease (iUPD)", "response_to_treatment_criteria_method": "Physician Assessed Response Criteria", "status_of_treatment": "Treatment incomplete due to technical or organizational problems", "submitter_treatment_id": "TREATMENT_22", "treatment_end_date": {"month_interval": 89, "day_interval": 2670}, "treatment_intent": "Palliative", "treatment_setting": "Radiosensitization", "treatment_start_date": {"month_interval": 45, "day_interval": 1350}, "radiations": [{"anatomical_site_irradiated": "Lower Limb", "radiation_boost": false, "radiation_therapy_dosage": 70, "radiation_therapy_fractions": 30, "radiation_therapy_modality": "Teleradiotherapy neutrons (procedure)", "radiation_therapy_type": "Internal"}], "followups": [{"date_of_followup": {"month_interval": 28, "day_interval": 840}, "date_of_relapse": {"month_interval": 13, "day_interval": 390}, "disease_status_at_followup": "Partial remission", "method_of_progression_status": ["Imaging (procedure)"], "recurrence_m_category": "M1b", "recurrence_n_category": "N3a", "recurrence_stage_group": "Stage 2B", "recurrence_t_category": "Tis(Paget's)", "recurrence_tumour_staging_system": "AJCC 8th edition", "relapse_type": "Local recurrence and distant metastasis", "submitter_follow_up_id": "FOLLOW_UP_31"}]}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 42, "comorbidity_treatment": "Other targeting molecular therapy", "comorbidity_type_code": "C02.1", "prior_malignancy": "Unknown"}], "exposures": [{"pack_years_smoked": 191, "tobacco_type": ["Cigar", "Chewing Tobacco"]}], "biomarkers": [{"er_status": "Cannot be determined", "her2_ihc_status": "Equivocal", "her2_ish_status": "Negative", "hpv_pcr_status": "Unknown", "hpv_strain": ["HPV16", "HPV18"], "pr_status": "Cannot be determined", "pr_percent_positive": 46.1, "psa_level": 214, "submitter_follow_up_id": "FOLLOW_UP_31", "test_date": {"month_interval": 5, "day_interval": 150}}]}, {"date_resolution": "day", "primary_site": ["Other endocrine glands and related structures"], "program_id": "SYNTHETIC-2", "sex_at_birth": "Female", "submitter_donor_id": "DONOR_8", "primary_diagnoses": [{"basis_of_diagnosis": "Death certificate only", "cancer_type_code": "C67.6", "clinical_n_category": "N3a", "clinical_stage_group": "Stage IBE", "clinical_t_category": "Tis(LAMN)", "clinical_tumour_staging_system": "AJCC 7th edition", "date_of_diagnosis": {"month_interval": 89, "day_interval": 2670}, "laterality": "Right", "lymph_nodes_examined_method": "Lymph node dissection/pathological exam", "lymph_nodes_examined_status": "No lymph nodes found in resected specimen", "number_lymph_nodes_positive": 3, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_14", "specimens": [{"pathological_m_category": "M1c", "pathological_stage_group": "Stage IV", "pathological_t_category": "T3(s)", "pathological_tumour_staging_system": "SEER staging system", "percent_tumour_cells_measurement_method": "Image analysis", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "No", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C43.1", "specimen_collection_date": {"month_interval": 49, "day_interval": 1470}, "specimen_laterality": "Not applicable", "specimen_processing": "Cryopreservation in liquid nitrogen (dead tissue)", "specimen_storage": "Frozen in -70 freezer", "submitter_specimen_id": "SPECIMEN_20", "tumour_grade": "Grade Group 4", "tumour_grading_system": "WHO grading system for CNS tumours", "tumour_histological_type": "8823/1", "sample_registrations": [{"sample_type": "Total DNA", "specimen_type": "Primary tumour - adjacent to normal", "submitter_sample_id": "SAMPLE_REGISTRATION_26"}]}], "treatments": [{"days_per_cycle": 7, "is_primary_treatment": "Unknown", "line_of_treatment": 1, "number_of_cycles": 4, "response_to_treatment": "Immune confirmed progressive disease (iCPD)", "response_to_treatment_criteria_method": "Cheson CLL 2012 Oncology Response Criteria", "status_of_treatment": "Treatment stopped due to lack of efficacy (disease progression)", "submitter_treatment_id": "TREATMENT_23", "treatment_intent": "Forensic", "treatment_setting": "Adjuvant", "treatment_start_date": {"month_interval": 38, "day_interval": 1140}, "treatment_type": ["Radiation therapy"], "surgeries": [{"greatest_dimension_tumour": 6, "lymphovascular_invasion": "Not applicable", "margin_types_not_assessed": ["Unknown", "Circumferential resection margin"], "margin_types_not_involved": ["Unknown"], "perineural_invasion": "Present", "residual_tumour_classification": "R0", "surgery_location": "Metastatic", "surgery_site": "C11", "surgery_type": "Wide Local Excision", "tumour_focality": "Not applicable", "tumour_length": 5, "tumour_width": 7}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C06"], "date_of_followup": {"month_interval": 43, "day_interval": 1290}, "date_of_relapse": {"month_interval": 20, "day_interval": 600}, "disease_status_at_followup": "Partial remission", "method_of_progression_status": ["Laboratory data interpretation (procedure)"], "recurrence_n_category": "N3b", "recurrence_stage_group": "Stage L2", "recurrence_t_category": "Tis(Paget)", "recurrence_tumour_staging_system": "Lugano staging system", "relapse_type": "Distant recurrence/metastasis", "submitter_follow_up_id": "FOLLOW_UP_32"}]}], "comorbidities": [{"age_at_comorbidity_diagnosis": 48, "comorbidity_treatment": "Radiation therapy", "comorbidity_treatment_status": "Yes", "comorbidity_type_code": "C43.9", "prior_malignancy": "Unknown"}], "exposures": [{"pack_years_smoked": 100, "tobacco_smoking_status": "Current reformed smoker for > 15 years", "tobacco_type": ["Pipe"]}]}, {"cause_of_death": "Unknown", "date_resolution": "day", "date_of_birth": {"month_interval": -750, "day_interval": -22500}, "date_of_death": {"month_interval": 40, "day_interval": 1200}, "gender": "Man", "is_deceased": true, "primary_site": ["Penis", "Other and unspecified parts of mouth", "Testis", "Adrenal gland"], "program_id": "SYNTHETIC-2", "sex_at_birth": "Male", "submitter_donor_id": "DONOR_9", "primary_diagnoses": [{"basis_of_diagnosis": "Cytology", "cancer_type_code": "C43.9", "clinical_m_category": "M1c(0)", "clinical_n_category": "N2b", "clinical_stage_group": "Stage IIAS", "clinical_t_category": "Tis(Paget's)", "clinical_tumour_staging_system": "St Jude staging system", "date_of_diagnosis": {"month_interval": 31, "day_interval": 930}, "laterality": "Right", "lymph_nodes_examined_method": "Physical palpation of patient", "lymph_nodes_examined_status": "No lymph nodes found in resected specimen", "number_lymph_nodes_positive": 9, "submitter_primary_diagnosis_id": "PRIMARY_DIAGNOSIS_15", "specimens": [{"pathological_m_category": "M1d", "pathological_n_category": "N1", "pathological_t_category": "Tis(LCIS)", "pathological_tumour_staging_system": "Rai staging system", "percent_tumour_cells_measurement_method": "Pathology estimate by percent nuclei", "percent_tumour_cells_range": "0-19%", "reference_pathology_confirmed_diagnosis": "No", "reference_pathology_confirmed_tumour_presence": "Not done", "specimen_anatomic_location": "C50.9", "specimen_collection_date": {"month_interval": 4, "day_interval": 120}, "specimen_laterality": "Unknown", "specimen_processing": "Fresh", "specimen_storage": "Paraffin block", "submitter_specimen_id": "SPECIMEN_21", "tumour_grade": "Grade 1", "tumour_grading_system": "FNCLCC grading system", "tumour_histological_type": "8209/3", "sample_registrations": [{"sample_type": "Total RNA", "specimen_tissue_source": "Synovial fluid", "specimen_type": "Cell line - derived from xenograft tumour", "submitter_sample_id": "SAMPLE_REGISTRATION_27"}]}], "treatments": [{"days_per_cycle": 5, "is_primary_treatment": "No", "line_of_treatment": 2, "number_of_cycles": 5, "response_to_treatment": "Complete remission without measurable residual disease (CR MRD-)", "response_to_treatment_criteria_method": "Physician Assessed Response Criteria", "status_of_treatment": "Patient choice (stopped or interrupted treatment)", "submitter_treatment_id": "TREATMENT_24", "treatment_end_date": {"month_interval": 76, "day_interval": 2280}, "treatment_intent": "Supportive", "treatment_setting": "Preventative", "treatment_start_date": {"month_interval": 31, "day_interval": 930}, "surgeries": [{"lymphovascular_invasion": "Venous (large vessel) invasion only", "margin_types_not_assessed": ["Proximal margin", "Distal margin"], "margin_types_not_involved": ["Common bile duct margin", "Circumferential resection margin"], "perineural_invasion": "Absent", "residual_tumour_classification": "R0", "surgery_location": "Metastatic", "surgery_site": "C08", "tumour_focality": "Cannot be assessed", "tumour_length": 8, "tumour_width": 3}]}], "followups": [{"anatomic_site_progression_or_recurrence": ["C04", "C19"], "date_of_followup": {"month_interval": 1, "day_interval": 30}, "date_of_relapse": {"month_interval": 14, "day_interval": 420}, "recurrence_m_category": "M1", "recurrence_n_category": "N0b", "recurrence_stage_group": "Stage IIIS", "recurrence_t_category": "Tis(DCIS)", "recurrence_tumour_staging_system": "St Jude staging system", "relapse_type": "Local recurrence", "submitter_follow_up_id": "FOLLOW_UP_33"}]}]}, {"cause_of_death": "Unknown", "date_resolution": "month", "date_of_death": {"month_interval": 90, "day_interval": 2700}, "gender": "Woman", "is_deceased": true, "primary_site": ["Floor of mouth"], "program_id": "SYNTHETIC-2", "sex_at_birth": "Other", "submitter_donor_id": "DONOR_11"}], "katsu_sha": "e817df8fed83826d957d99e51b61753e3bac302a", "validation_errors": [], "validation_warnings": ["DONOR_1 > PRIMARY_DIAGNOSIS_1 > SPECIMEN_3: Tumour specimens require a reference_pathology_confirmed_tumour_presence", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > SPECIMEN_3: Tumour specimens require a percent_tumour_cells_range", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > TREATMENT_1 > FOLLOW_UP_1: anatomic_site_progression_or_recurrence is required if disease_status_at_followup is Loco-regional progression", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > TREATMENT_1 > FOLLOW_UP_2: relapse_type is required if disease_status_at_followup is Distant progression", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > TREATMENT_2: treatment type Hormonal therapy should have one or more hormone_therapies submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > TREATMENT_3 > Chemotherapy 1: chemotherapy_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_1 > TREATMENT_3 > Chemotherapy 1: chemotherapy_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_2: lymph_nodes_examined_method required if lymph_nodes_examined_status = Yes", "DONOR_1 > PRIMARY_DIAGNOSIS_2 > SPECIMEN_6: Tumour specimens require a reference_pathology_confirmed_tumour_presence", "DONOR_1 > PRIMARY_DIAGNOSIS_2 > TREATMENT_5: treatment type Hormonal therapy should have one or more hormone_therapies submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_2 > TREATMENT_5: treatment type Surgery should have one or more surgery submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_2 > TREATMENT_6: treatment type Surgery should have one or more surgery submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_2 > TREATMENT_6 > Chemotherapy 0: chemotherapy_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_1 > PRIMARY_DIAGNOSIS_3 > SPECIMEN_7: Tumour specimens require a reference_pathology_confirmed_tumour_presence", "DONOR_1 > PRIMARY_DIAGNOSIS_3 > SPECIMEN_7: Tumour specimens require a percent_tumour_cells_measurement_method", "DONOR_1 > PRIMARY_DIAGNOSIS_3 > SPECIMEN_8: Tumour specimens require a percent_tumour_cells_range", "DONOR_1 > PRIMARY_DIAGNOSIS_3 > TREATMENT_9: treatment type Immunotherapy should have one or more immunotherapies submitted", "DONOR_10 > PRIMARY_DIAGNOSIS_16 > SPECIMEN_22: Tumour specimens require a reference_pathology_confirmed_diagnosis", "DONOR_10 > PRIMARY_DIAGNOSIS_16 > SPECIMEN_22: Tumour specimens require a tumour_grading_system", "DONOR_10 > PRIMARY_DIAGNOSIS_16 > SPECIMEN_22: Tumour specimens require a percent_tumour_cells_measurement_method", "DONOR_10 > PRIMARY_DIAGNOSIS_16 > FOLLOW_UP_34: date_of_relapse is required if disease_status_at_followup is Relapse or recurrence", "DONOR_10 > PRIMARY_DIAGNOSIS_16 > FOLLOW_UP_34: method_of_progression_status is required if disease_status_at_followup is Relapse or recurrence", "DONOR_12: test_date is required for biomarkers not associated with nested events", "DONOR_12: test_date is required for biomarkers not associated with nested events", "DONOR_12: test_date is required for biomarkers not associated with nested events", "DONOR_12: test_date is required for biomarkers not associated with nested events", "DONOR_12 > PRIMARY_DIAGNOSIS_1a > TREATMENT_1a > Hormone Therapy 0: hormone_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_12 > PRIMARY_DIAGNOSIS_1a > TREATMENT_1a > Hormone Therapy 0: hormone_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_12 > PRIMARY_DIAGNOSIS_1a > TREATMENT_2a > Chemotherapy 0: chemotherapy_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_12 > PRIMARY_DIAGNOSIS_1a > TREATMENT_2a > Chemotherapy 1: chemotherapy_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_12 > Exposure 1: tobacco_smoking_status required for exposure", "DONOR_2 > PRIMARY_DIAGNOSIS_6: lymph_nodes_examined_method required if lymph_nodes_examined_status = Yes", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > TREATMENT_14: treatment type Hormonal therapy should have one or more hormone_therapies submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > TREATMENT_14 > Immunotherapy 0: immunotherapy_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > TREATMENT_14 > Immunotherapy 1: immunotherapy_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > TREATMENT_14 > Immunotherapy 1: immunotherapy_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > FOLLOW_UP_23: method_of_progression_status is required if disease_status_at_followup is Relapse or recurrence", "DONOR_2 > PRIMARY_DIAGNOSIS_6 > FOLLOW_UP_23: anatomic_site_progression_or_recurrence is required if disease_status_at_followup is Relapse or recurrence", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > SPECIMEN_9: Tumour specimens require a reference_pathology_confirmed_diagnosis", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > SPECIMEN_9: Tumour specimens require a percent_tumour_cells_measurement_method", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > SPECIMEN_10: Tumour specimens require a reference_pathology_confirmed_tumour_presence", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > TREATMENT_11 > Hormone Therapy 1: hormone_drug_dose_units required if actual_cumulative_drug_dose is submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > TREATMENT_10: treatment type Immunotherapy should have one or more immunotherapies submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_4 > TREATMENT_10 > Hormone Therapy 0: hormone_drug_dose_units required if prescribed_cumulative_drug_dose is submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_5: clinical_m_category is required if clinical_tumour_staging_system is AJCC", "DONOR_2 > PRIMARY_DIAGNOSIS_5 > SPECIMEN_11: Tumour specimens require a percent_tumour_cells_measurement_method", "DONOR_2 > PRIMARY_DIAGNOSIS_5 > TREATMENT_13: treatment type Surgery should have one or more surgery submitted", "DONOR_2 > PRIMARY_DIAGNOSIS_5 > TREATMENT_12: treatment type Chemotherapy should have one or more chemotherapies submitted", "DONOR_4: lost_to_followup_after_clinical_event_identifier is required if date_alive_after_lost_to_followup is submitted", "DONOR_4 > PRIMARY_DIAGNOSIS_10: lymph_nodes_examined_method required if lymph_nodes_examined_status = Yes", "DONOR_4 > PRIMARY_DIAGNOSIS_10 > SPECIMEN_16: Tumour specimens require a percent_tumour_cells_measurement_method", "DONOR_4 > PRIMARY_DIAGNOSIS_10 > TREATMENT_19: treatment type Chemotherapy should have one or more chemotherapies submitted", "DONOR_4 > PRIMARY_DIAGNOSIS_9 > SPECIMEN_15: Tumour specimens require a percent_tumour_cells_range", "DONOR_4 > PRIMARY_DIAGNOSIS_9 > FOLLOW_UP_27: method_of_progression_status is required if disease_status_at_followup is Distant progression", "DONOR_5 > PRIMARY_DIAGNOSIS_11: clinical_n_category is required if clinical_tumour_staging_system is AJCC", "DONOR_5 > PRIMARY_DIAGNOSIS_11 > SPECIMEN_17: Tumour specimens require a reference_pathology_confirmed_diagnosis", "DONOR_5 > PRIMARY_DIAGNOSIS_11 > TREATMENT_20 > FOLLOW_UP_29: date_of_relapse is required if disease_status_at_followup is Loco-regional progression", "DONOR_5 > PRIMARY_DIAGNOSIS_11 > TREATMENT_20 > FOLLOW_UP_29: anatomic_site_progression_or_recurrence is required if disease_status_at_followup is Loco-regional progression", "DONOR_6 > PRIMARY_DIAGNOSIS_12: clinical_stage_group is required for clinical_tumour_staging_system SEER staging system", "DONOR_6 > PRIMARY_DIAGNOSIS_12 > SPECIMEN_18: Tumour specimens require a reference_pathology_confirmed_tumour_presence", "DONOR_6 > PRIMARY_DIAGNOSIS_12 > TREATMENT_21: treatment type Surgery should have one or more surgery submitted", "DONOR_6 > PRIMARY_DIAGNOSIS_12 > FOLLOW_UP_30: date_of_relapse is required if disease_status_at_followup is Relapse or recurrence", "DONOR_7 > Exposure 0: tobacco_smoking_status required for exposure", "DONOR_8 > PRIMARY_DIAGNOSIS_14: clinical_m_category is required if clinical_tumour_staging_system is AJCC", "DONOR_8 > PRIMARY_DIAGNOSIS_14 > TREATMENT_23: treatment type Radiation therapy should have one or more radiation submitted"], "statistics": {"required_but_missing": {"donors": {"submitter_donor_id": {"total": 12, "missing": 0}, "gender": {"total": 12, "missing": 3}, "sex_at_birth": {"total": 12, "missing": 4}, "is_deceased": {"total": 12, "missing": 4}, "program_id": {"total": 12, "missing": 0}, "date_resolution": {"total": 12, "missing": 0}, "date_of_birth": {"total": 12, "missing": 5}, "primary_site": {"total": 12, "missing": 2}}, "primary_diagnoses": {"submitter_primary_diagnosis_id": {"total": 17, "missing": 0}, "date_of_diagnosis": {"total": 17, "missing": 1}, "cancer_type_code": {"total": 17, "missing": 3}, "basis_of_diagnosis": {"total": 17, "missing": 3}, "lymph_nodes_examined_status": {"total": 17, "missing": 3}}, "specimens": {"submitter_specimen_id": {"total": 23, "missing": 0}, "specimen_collection_date": {"total": 23, "missing": 2}, "specimen_storage": {"total": 23, "missing": 5}, "specimen_anatomic_location": {"total": 23, "missing": 3}}, "sample_registrations": {"submitter_sample_id": {"total": 30, "missing": 0}, "specimen_tissue_source": {"total": 30, "missing": 5}, "specimen_type": {"total": 30, "missing": 7}, "sample_type": {"total": 30, "missing": 6}}, "treatments": {"submitter_treatment_id": {"total": 27, "missing": 0}, "treatment_type": {"total": 27, "missing": 10}, "is_primary_treatment": {"total": 27, "missing": 3}, "treatment_start_date": {"total": 27, "missing": 4}, "treatment_end_date": {"total": 27, "missing": 6}, "treatment_setting": {"total": 27, "missing": 6}, "treatment_intent": {"total": 27, "missing": 6}, "response_to_treatment_criteria_method": {"total": 27, "missing": 5}, "response_to_treatment": {"total": 27, "missing": 6}}, "chemotherapies": {"drug_reference_database": {"total": 18, "missing": 5}, "drug_name": {"total": 18, "missing": 3}, "drug_reference_identifier": {"total": 18, "missing": 6}}, "followups": {"submitter_follow_up_id": {"total": 33, "missing": 0}, "date_of_followup": {"total": 33, "missing": 4}, "disease_status_at_followup": {"total": 33, "missing": 6}}, "hormone_therapies": {"drug_reference_database": {"total": 17, "missing": 7}, "drug_name": {"total": 17, "missing": 3}, "drug_reference_identifier": {"total": 17, "missing": 6}}, "comorbidities": {"comorbidity_type_code": {"total": 17, "missing": 3}}, "exposures": {}, "biomarkers": {}, "surgeries": {"surgery_type": {"total": 6, "missing": 3}}, "immunotherapies": {"drug_reference_database": {"total": 14, "missing": 2}, "drug_name": {"total": 14, "missing": 3}, "drug_reference_identifier": {"total": 14, "missing": 2}}, "radiations": {"radiation_therapy_modality": {"total": 7, "missing": 3}, "radiation_therapy_type": {"total": 7, "missing": 3}, "anatomical_site_irradiated": {"total": 7, "missing": 2}, "radiation_therapy_fractions": {"total": 7, "missing": 3}, "radiation_therapy_dosage": {"total": 7, "missing": 3}}}, "schemas_used": ["donors", "primary_diagnoses", "specimens", "sample_registrations", "treatments", "chemotherapies", "followups", "hormone_therapies", "comorbidities", "exposures", "biomarkers", "surgeries", "immunotherapies", "radiations"], "cases_missing_data": ["DONOR_1", "DONOR_10", "DONOR_12", "DONOR_2", "DONOR_3", "DONOR_4", "DONOR_5", "DONOR_6", "DONOR_7", "DONOR_8", "DONOR_9", "DONOR_11"], "schemas_not_used": [], "summary_cases": {"complete_cases": 0, "total_cases": 12}}}